BNP Paribas Financial Markets
TRIV

BNP Paribas Financial Markets’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

BNP Paribas Financial Markets’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-180
Closed -$1.89K – 3715
2015
Q1 		$1.89K Buy
+180
New +$1.85K ﹤0.01% 3481
2014
Q4 		– Sell
-422
Closed -$6.11K – 3945
2014
Q3 		$6.11K Buy
+422
New +$6.13K ﹤0.01% 3766

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's TRIV Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 180 shares — an estimated $1.89K sold.

BNP Paribas Financial Markets first reported a position in TRIV in Q3 2014 and held it in 2 quarters. The position peaked at $6.11K in Q3 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.

  • BNP Paribas Financial Markets reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 180 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $1.89K.
  • BNP Paribas Financial Markets first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 2 quarters.
  • BNP Paribas Financial Markets's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $6.11K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.